News

Telecom stocks are often reliable income investments to own, but investors aren't so sure that's the case with AT&T (NYSE: T). The stock yields 7.6% right now, as its share price has fallen 19% this

Shares of the brain-health specialist Sage Therapeutics (NASDAQ: SAGE) are having a tough trading session today. Specifically, the biotech's stock was down by approximately 13% on heavy volume as of

Image source: The Motley Fool.

AT&T (NYSE: T)Q2 2023 Earnings CallJul 26, 2023, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

One thing that can often drive up a stock's value is an increase in guidance. And two companies that recently boosted their projections for the year are Novartis (NYSE: NVS) and PepsiCo (NASDAQ:

There's one main downside to the tremendous performance of the stock market so far in 2023. Many stocks are now priced for perfection. And unfortunately, perfection is rarely attainable.

The good

If you've only recently learned about Invitae (NYSE: NVTA), you can consider yourself lucky. A few years ago, the diagnostics business wowed Wall Street with plans to bring genetic testing to the

Typically, when a publicly traded company reports an estimates-beating quarter, its stock price rises in reaction. There are always exceptions, though, and on Tuesday it was Biogen's (NASDAQ: BIIB)

Image source: The Motley Fool.

Biogen (NASDAQ: BIIB)Q2 2023 Earnings CallJul 25, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

There are several reasons many investors gravitate toward dividend stocks. Some are attracted to the regular income stream, while others opt for dividend reinvestment to boost long-term returns

Over the past two years, AT&T (NYSE: T) tried to reset its business by selling its non-core assets and spinning off DirecTV and WarnerMedia. It claimed that a big reversal of its media expansion

Nvidia became the world's first trillion-dollar chipmaker this May, making it more than three times more valuable than Intel and Advanced Micro Devices combined. Nvidia's valuation skyrocketed to

Fool.com contributor Parkev Tatevosian evaluates AT&T's (NYSE: T) prospects to determine whether its dividend payments are sustainable in the long run.

*Stock prices used were the afternoon prices

When you think of biotech companies, you may think of up-and-coming players with exciting pipelines, but zero marketed products. These could make interesting investment opportunities. But they often

For a dividend investor, generating enough income to become and stay financially independent (higher passive income than expenses) comes down in large part to the longevity of the businesses in an

Think small. It's one of the best ideas for investors seeking to reap returns that trounce the overall market.

Three Motley Fool contributors identified small-cap stocks that they think could

Even if you don't recognize the name Viatris (NASDAQ: VTRS), you may have come in very close contact with this pharma company. It sells a wide variety of generic drugs -- such as generic Zyrtec

In retirement, seniors on average see an annual shortfall of about $4,000 between the income they generate and the expenses they incur, according to data from the Bureau of Labor Statistics

Investors looking for stocks with explosive growth potential would do well to take a gander at the biotech industry. Clinical and regulatory wins can fuel excellent stock market performances for

Last April, AT&T (NYSE: T) spun off WarnerMedia and merged it with Discovery to create new-media giant Warner Bros. Discovery (NASDAQ: WBD). That spinoff, along with its divestment of DirecTV in